NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
ACS Management Innovations: Transforming Patient Outcomes in Acute Coronary S...
CVD Prevention Models in Sub-Saharan Africa: Insights and Gaps
Gauteng HPV Vaccination Campaign: Protecting Girls Against Cervical Cancer
NICE Approves Gene Therapy for Sickle Cell: A Breakthrough in Treatment and H...
Cervical Cancer App: Enhancing Screening and Treatment
Streamlining HTA – Joint Scientific Consultations in the EU
Boosting HPV Vaccine Uptake Among Young People Post-Pandemic
MENA Generics Biologics Healthcare Innovation
U.S. Withdraws from WHO: Impact on Global Health Security and Relations
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Blueprint for Transforming Healthcare Access in Africa
GLP-1 Receptor Agonists: Balancing Benefits and Risks in Treatment Decisions